"Your firm offers 'Bacteriostatic Water' for sale alongside peptide products, which are drugs intended for injection and require reconstitution" said FDA in its letter to Lovega
That raises the prospect, she said, that patients will stop taking the drugs and regain weight, which will lead to poor clinical outcomes. Join our commenting forum Join thought-provoking conversations, follow other Independent readers and see their replies Comments
Would you like help creating a detailed patient guide for these formulations or comparing them with other GLP-1 treatments
in medical terms, this is known as goitre
Appetite control is important, but it is not the only factor involved in obesity
provide batch-specific CoA documentation including HPLC and LC-MS data